000			03548cam a2200349 a 4500
003			EG-GiCUC
005			20250223031547.0
008			160919s2016 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.08.03.M.Sc.2016.Ya.A
100	0		_aYasmine Farouk Metwally Bassuoni
245	1	0	_aAnalytical study on some locally acting pharmaceutical drugs / _cYasmine Farouk Metwally Bassuoni ; Supervised Hala Elsayed Zaazaa , Eman Saad Elzanfaly , Hebatallah Mohamed Essam
246	1	5	_aدراسة تحليلية على بعض الأدوية ذات التأثير الموضعي
260			_aCairo : _bYasmine Farouk Metwally Bassuoni , _c2016
300			_a186 P. : _bcharts ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Analytical Chemistry
520			_aThis thesis consists of four parts including, the scientific study, literature review, references and summaries. Part {u04C0}: General introduction for locally acting drugs was presented. Part {u04C0}{u04C0}: Stability-indicating methods for determination of Clobetasol propionate in presence of its alkaline degradation products which includes five sections, Section A: Introduction and Literature Review for Clobetasol propionate were discussed, Section B: Forced degradation studies of Clobetasol propionate under alkaline stress condition were presented, Section C: it includes stability indicating TLC {u2013} densitometric method for the determination of Clobetasol propionate in presence of its alkaline degradation products, Section D: it includes first derivative of ratio spectrophotometric method for determination of Clobetasol propionate in presence of either its alkaline degradation products or Chlorocresol preservative present in its pharmaceutical formulation and Section E: ratio difference spectrophotometric method for determination of Clobetasol propionate in presence of its alkaline degradation products and Chlorocresol in its pharmaceutical formulation. Part {u04C0}{u04C0}{u04C0}: Determination of Benzydamine HCl and co-formulated compounds in its single or ternary mixture pharmaceutical formulations it includes three sections, Section A: includes introduction and literature review for Benzydamine HCl, Benzocaine and Cetalkonium chloride, Section B: includes potentiometric determination of Benzydamine HCl in its pharmaceutical formulations by Ion Selective Electrode and Section C: determination of Benzyadmine HCl, Benzocaine and Cetalkonium Chloride present in their spray form, which includes three subsections, Subsection (a): HPLC method for determination of Benzydamine HCl and Benzocaine, Subsection (b): TLC {u2013} densitometric method for determination of Benzydamine HCl and Benzocaine and Subsection (c): includes potentiometric determination of Cetalkonium Chloride by Ion Selective Electrode. Part VI: Determination of Cetrimide and co-formulated compounds Lidocaine HCl and Chlorhexidine Gluconate in their combined pharmaceutical formulations,
530			_aIssued also as CD
653		4	_aBenzydamine HCl
653		4	_aCetalkonium chloride
653		4	_aClobetasol propionate
700	0		_aEman Saad Elzanfaly , _eSupervisor
700	0		_aHala Elsayed Zaazaa , _eSupervisor
700	0		_aHebatallah Mohamed Essam , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aEnas _eCataloger
905			_aNazla _eRevisor
942			_2ddc _cTH
999			_c57760 _d57760